Kathryn Gallaway, MD
@ke_gallaway
34 y/o G2P2 presents w/ insatiable thirst for knowledge of unknown etiology | Philosophy @RiceUniversity | MD @UTSWNews | Associate Medical Director @DAVAOnc
ID: 1558842292605259777
https://www.linkedin.com/in/kathryn-gallaway-845136236/ 14-08-2022 15:46:19
958 Tweet
383 Followers
917 Following
Phenomenal work from Mark Roschewski diving into the biology and treatment strategies of immune privileged LBCL ashpublications.org/blood/article-… Looking forward to updated data from trials considering response adapted chemo after ibrutinib a window study for acalabrutinib